Synthesis, radiolabeling and animal studies of [¹³¹I]MPPI: A 5-HT_1A imaging agent

详细信息    查看全文

• 作者：Bai-Shan SUN ; Chun-Xiong LU ; Mei-Fen ZOU ; Quan-Fu JIANG ; Song-Pei WANG ; Xiao-Min LI ; Zheng-Ping CHEN ; Jun-Qing ZHU ; Chun-Ying WU
• 关键词：5-HT_1A ; [¹³¹I]MPPI ; Synthesis ; Biological evaluation ; Imaging agent ; Biodistribution
  CLC number ; R817
• 刊名：Nuclear Science and Techniques
• 出版年：2006
• 出版时间：February 2006
• 年：2006
• 卷：17
• 期：1
• 页码：43-47
• 全文大小：548 K

文摘

The synthesis and biological evaluation of serotonin (5-HT_1A) imaging agent [¹³¹I]-4-iodo-N-{2-[4-(2-methoxyphenyl)-piperazin-1-yl]-ethyl}-N-pridin-n-2-yl-benzamide ([¹³¹I]MPPI) are reported. The chemical structure of aimed compound and intermediates were confirmed by IR, ¹HNMR, and MS. Radiochemical purity was above 99 % determined by TLC. Biodistribution of [¹³¹I]MPPI in rats displayed high uptake in hippocampus and low uptake in cerebellum. The ratio of the uptake of [¹³¹I]MPPI in hippocampus to that in cerebellum was 2.90 at 30 min post injection. The radioactivity in thyroid was 0.069 and 0.128 % ID/g organ at 5 min and 120 min, respectively, and it was increased with time, which suggests that in vivo deiodination may be the major route of metabolism. Ex vivo autoradiography of brain section displayed significant decrease of radioactivity in hippocampus when pretreated with 8-OH-DPAT, a selective 5HT_1A agonist, compared with control. These findings strongly suggested that ¹³¹I-MPPI could be used as an in vivo marker for studies of pharmacology of the 5-HT_1A receptor system in animals.